Cargando…

Clustering and prediction of disease progression trajectories in Huntington's disease: An analysis of Enroll-HD data using a machine learning approach

INTRODUCTION: Huntington's disease (HD) is a rare neurodegenerative disease characterized by cognitive, behavioral and motor symptoms that progressively worsen with time. Cognitive and behavioral signs of HD are generally present in the years prior to a diagnosis; however, manifest HD is typica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ko, Jinnie, Furby, Hannah, Ma, Xiaoye, Long, Jeffrey D., Lu, Xiao-Yu, Slowiejko, Diana, Gandhy, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923354/ https://www.ncbi.nlm.nih.gov/pubmed/36793800 http://dx.doi.org/10.3389/fneur.2022.1034269

Ejemplares similares

Prevalence of neurocognitive disorder in Huntington’s disease using the Enroll-HD dataset
por: Sierra, Luis A., et al.
Publicado: (2023)

Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
por: Sathe, Swati, et al.
Publicado: (2021)

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
por: Rocha, Natalia P., et al.
Publicado: (2018)

Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
por: Ouwerkerk, Jasper, et al.
Publicado: (2023)

Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study
por: Ogilvie, Amy C., et al.
Publicado: (2023)

Exploring the predictors of financial impairment in Huntington’s disease using the Enroll-HD dataset
por: Harris, Kate L., et al.
Publicado: (2022)

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
por: Harris, Kate L, et al.
Publicado: (2020)

A Phenotypic Atlas for Huntington Disease Based on Data From the Enroll-HD Cohort Study
por: Langbehn, Douglas R., et al.
Publicado: (2023)

Another Perspective on Huntington’s Disease: Disease Burden in Family Members and Pre-Manifest HD When Compared to Genotype-Negative Participants from ENROLL-HD
por: Achenbach, Jannis, et al.
Publicado: (2021)

Protocol for REducing Anti-Psychotic use in residential care-Huntington Disease (REAP-HD): a pilot cluster randomised controlled trial of a multifaceted intervention for health professionals
por: Loy, Clement T, et al.
Publicado: (2014)

A randomised feasibility study of computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD)
por: Yhnell, Emma, et al.
Publicado: (2020)

Disease Burden of Huntington’s Disease (HD) on People Living with HD and Care Partners in Canada
por: Shaw, Eileen, et al.
Publicado: (2022)

Refining the diagnosis of Huntington disease: the PREDICT-HD study
por: Biglan, Kevin M., et al.
Publicado: (2013)

Assessing the state of care for Huntington disease in the United States: Results from a survey of practices treating Huntington disease patients
por: Seeberger, Lauren, et al.
Publicado: (2022)

Exploring computerised cognitive training as a therapeutic intervention for people with Huntington’s disease (CogTrainHD): protocol for a randomised feasibility study
por: Yhnell, Emma, et al.
Publicado: (2018)

Genetic and Environmental Contributors to Neurodegeneration: An Exploration of the Effects of Alcohol on Clinical Features of Huntington’s Disease Using the Enroll-HD Global Platform
por: Symonds, Alexander L., et al.
Publicado: (2021)

Molecule of the month: miRNA and Huntington's disease (HD)
por: Shapshak, Paul
Publicado: (2013)

Understanding HD Psychosis: An Analysis from the ENROLL-HD Database
por: Jaini, Ashwin, et al.
Publicado: (2020)

Mild Cognitive Impairment as an Early Landmark in Huntington's Disease
por: Zhang, Ying, et al.
Publicado: (2021)

Multivariate prediction of motor diagnosis in Huntington's disease: 12 years of PREDICT‐HD
por: Long, Jeffrey D., et al.
Publicado: (2015)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Is Ataxia an Underestimated Symptom of Huntington's Disease?
por: Franklin, Gustavo L., et al.
Publicado: (2020)

Study Protocol for the Development of a European eHealth Platform to Improve Quality of Life in Individuals With Huntington's Disease and Their Partners (HD-eHelp Study): A User-Centered Design Approach
por: van Lonkhuizen, Pearl J. C., et al.
Publicado: (2021)

Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study
por: Klöppel, Stefan, et al.
Publicado: (2015)

Ranking the Predictive Power of Clinical and Biological Features Associated With Disease Progression in Huntington's Disease
por: Ghazaleh, Naghmeh, et al.
Publicado: (2021)

Detection of Huntington’s disease decades before diagnosis: the Predict-HD study
por: Paulsen, J S, et al.
Publicado: (2008)

Nrf2 Pathway in Huntington’s Disease (HD): What Is Its Role?
por: Tucci, Paolo, et al.
Publicado: (2022)

Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects
por: Abreu, Daisy, et al.
Publicado: (2021)

Targeting Tau to Treat Clinical Features of Huntington's Disease
por: Masnata, Maria, et al.
Publicado: (2020)

Case report: Cerebellar sparing in juvenile Huntington's disease
por: Santos-Lobato, Bruno Lopes, et al.
Publicado: (2023)

Natural history and burden of Huntington's disease in the UK: A population‐based cohort study
por: Furby, Hannah, et al.
Publicado: (2022)

Altered cerebrovascular response to acute exercise in patients with Huntington’s disease
por: Steventon, Jessica J, et al.
Publicado: (2020)

DNA Methylation Profiles in Whole Blood of Huntington's Disease Patients
por: Zadel, Maja, et al.
Publicado: (2018)

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?
por: Migliore, Simone, et al.
Publicado: (2019)

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review
por: Kinnunen, Kirsi M., et al.
Publicado: (2021)

Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia
por: Saba, Julieta, et al.
Publicado: (2022)

Stem Cells for Huntington’s Disease (SC4HD): An International Consortium to Facilitate Stem Cell-Based Therapy for Huntington’s Disease
Publicado: (2021)

MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD study
por: Reed, Eric R., et al.
Publicado: (2018)

Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials
por: Kinnunen, Kirsi M., et al.
Publicado: (2021)

Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s Disease
por: Mansoor, Nina M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_es9q2n0reo7vcasgaok930o9n2